Cramer’s Got His Eye on Allergan, Himax, and These 3 Stocks

Jim Cramer made the following calls on August 1st, 2013. What do you think about his picks?

Allergan Inc. (NYSE:AGN): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on May 6, 2013. The stock’s 52-week high is $116.45, and its 52-week low is $81.33.

David Pyott, chairman and CEO of Allergan, came on Cramer last night to discuss the state of his business. After beating market expectations for earnings, Pyott noted that while a generic competitor for one of its eye medications looms, the FDA has got it tied up in reviews, meaning less competition for Allergan for the time being.